Medicare Advantage False Claims Act: When the Company Knows the Payment Is Wrong

Medicare Advantage False Claims Act cases can pursue knowingly false payment data, false certifications and money kept after a known overpayment. For someone inside a plan, medical group or coding vendor, the revealing moment may come after the review: the company learns that a diagnosis lacks support, then continues using it to collect Medicare money. In Medicare Advantage fraud, taxpayers can end up paying for conditions patients do not have.

Does the False Claims Act Apply to Medicare Advantage Plans?

Yes. The False Claims Act applies to Medicare Advantage payment claims, including claims driven by knowingly false diagnosis data and efforts to keep money the plan knows it owes back. Medicare Advantage is Medicare Part C, the private-plan option within Medicare. The government makes a capitated payment: a monthly amount for each member’s coverage.

The connection between a diagnosis and that payment is risk adjustment. The Centers for Medicare & Medicaid Services groups eligible diagnoses into Hierarchical Condition Categories representing expected health care costs. It uses those categories and the member’s other characteristics to calculate a risk score. The score multiplies the plan’s base payment. A diagnosis can therefore increase the government’s payment without producing a separate bill for another office visit.

That path from a medical record to monthly revenue explains why coding and compliance staff can see something consequential before it reaches a payment report. A healthcare provider records the condition, a reviewer or vendor extracts the code, and the plan submits it. In risk adjustment fraud, the evidence connects the unsupported information to the money and to the people who knew about it.

How the False Claims Act Reaches the Payment

The same diagnosis can raise separate questions about the original claim, a later refund and the assurance that the data are accurate. Each question calls for a different part of the company’s records.

Knowingly False Payment Data

The False Claims Act reaches those who knowingly submit false claims or cause someone else to submit them. It also reaches someone who knowingly uses a false record or statement that can affect whether a false claim gets paid.

The case allegations below describe diagnoses added for conditions physicians had not addressed during a visit, diagnoses based only on medication history, and cardiac conditions contradicted by testing. The question is what the company knew about that missing or conflicting support when it sent the code to Medicare for payment.

The law also reaches deliberately avoiding the truth and recklessly disregarding it. A dated audit, a provider’s objection or an instruction to override a reviewer can help explain how the business reached its decision.

Keeping a Known Overpayment

The repayment question concerns money already received. The Medicare Advantage overpayment rule requires plans to report and return identified overpayments. The False Claims Act reaches a plan that knowingly and improperly avoids paying that money back.

That is a reverse false claim. The evidence follows what the company learned after payment, who received that finding and what happened to the refund. An audit result and a later submission can tell different parts of the story.

The correction also has to reach the data that drives payment. A change confined to an internal billing file may leave the diagnosis in the information the insurer uses. We connect the finding, the instruction and the actual payment data to understand what the company corrected and what it kept.

Certifying Data the Company Knows Are Wrong

Payment certifications put the company’s assurance about its data in writing. The Medicare Advantage contract rule requires the chief executive, chief financial officer or a direct delegate to certify that submitted data are accurate, complete and truthful, to the best of their knowledge. The rule also reaches data generated by contractors and other entities through their accuracy certifications.

The question is what stood behind that assurance. Which review findings reached the people responsible for the certification? What did they say about the diagnoses still being submitted? A knowingly false certification can help get an unsupported diagnosis paid. That takes us from the signature back into the business that supplied it.

One-Way Chart Reviews Show What the Business Chose

One-way chart reviews use findings that increase payment while leaving identified unsupported codes in place. A review can produce both kinds of information. The company’s treatment of the results reveals the direction it chose.

In its complaint against Anthem, the government alleged that the insurer presented chart review to providers as an accuracy check while using the results only to add diagnoses. The complaint described an executive’s response when changing the program came up:

The government alleged that Anthem sold providers on accuracy while an executive defended the cash cow. Correcting the diagnoses would have threatened the very revenue the review was built to produce.

The Records That Connect Knowledge to Payment

The useful evidence follows a diagnosis through the organization: the encounter record, the code extracted from it, the submission, the resulting payment and any later correction. Dated messages and audit findings show who learned what along the way.

A query asking a physician to reopen a closed encounter can be compared with the original visit note. A vendor’s additions file can be compared with its findings about unsupported codes. A compliance report can be read alongside the later instructions about refunds or future submissions. These comparisons give the company’s knowledge a date and a decision.

For the coder, the problem may be visible in the record. For finance, it may appear in a forecast of revenue lost if corrections go through. For compliance, it may be an audit finding followed by a narrowed review or a stopped correction. What management did with the finding connects those views. We work with insiders to understand that sequence and its effect on Medicare’s payments.

Who Is Liable for Medicare Advantage Risk-Adjustment Fraud?

Plans, provider groups, coding and assessment vendors, and individuals can face False Claims Act claims for their own knowing conduct. The Act reaches causing a false claim as well as submitting it. A business can supply the false information while another business sends it to Medicare.

HealthCare Partners, doing business as DaVita Medical Holdings, settled in 2018. The government described a provider group whose coding practices allegedly caused plans to obtain inflated payments that the group shared. The settlement also resolved a whistleblower’s allegations that the group searched for missed diagnoses while ignoring inaccurate codes that should have been deleted.

The Seoul Medical Group settlement announced in 2025 shows another role for a contractor. The government alleged that the group submitted diagnoses for severe spinal conditions patients did not have. When a plan questioned one of those conditions, the group allegedly enlisted Renaissance Imaging Medical Associates to create radiology reports that appeared to support it. The radiology group separately settled the allegations against it.

Assessment vendors can also cause plans to submit false data. In its 2026 Matrix and HealthFair settlement announcement, the government alleged that HealthFair providers diagnosed conditions without confirming documentation, relied on patient statements or medication history, and in some instances reported cardiac conditions contradicted by testing.

False Claims Beyond Diagnosis Data

The government’s 2025 broker complaint alleged that insurers paid brokers illegal kickbacks in exchange for enrollments. In that setting, broker payments and enrollment arrangements supply the transaction to examine.

CareCore, a utilization-management company, admitted improperly approving prior authorizations in a 2017 settlement covering Medicare Part C and Medicaid. Its program pushed requests through as contractual deadlines approached, without new medical information or independent physician review. Plans paid for diagnostic procedures after the vendor approved them without the required review.

What the Medicare Advantage Cases Show

Aetna’s review results, Kaiser’s physician queries and Cigna’s home-visit forms each supplied a different route into the company’s decisions.

Aetna Had the Results of the Review

Aetna settled in March 2026 to resolve chart-review and morbid-obesity allegations. For the chart-review component, the government alleged that Aetna used review results to add diagnoses for payment year 2015 while leaving previously submitted codes that the reviews had failed to substantiate.

The relevant information was already inside the review operation. The alleged choice concerned which findings reached Medicare and which findings would have required repayment. That is why the reviewer output and the submission history matter together.

Kaiser’s Addendum Allegations Included Internal Warnings

Kaiser Permanente’s January 2026 settlement was $556 million. The announced whistleblower share was $95 million. The government alleged that Kaiser pressured physicians to add diagnoses they had not considered or addressed during the visits, tied financial incentives to diagnosis goals and ignored warnings from physicians and compliance audits.

The later addendum and the original encounter create a dated comparison. The government’s allegations also connected the requests to targets and internal objections. For an insider, those records can show who sought the change and what the company had been told about it.

Cigna’s Home-Visit Resolution Included Factual Admissions

Cigna made factual admissions in the home-visit component of its 2023 settlement. The Justice Department’s local account described diagnoses unsupported by the information on vendor forms, along with clinicians who lacked the testing needed to diagnose the serious conditions reported.

That component concerned the evidence produced during home assessments. The forms, diagnostic work and instructions to vendors explain what information the plan was buying and submitting.

Payment Incentives Leave a Measurable Trace

A 2019 Health Management Policy and Innovation study, Comparing Diagnostic Coding Intensity for Medicare Advantage and Fee for Service, compared diagnosis data using both the risk measure used for payment and another diagnosis-based measure. Its design gives an insider a useful question: how much of the apparent difference depends on the measure that pays?

Using national claims samples from 2010 through 2014, the study found similar scores from the two methods in fee-for-service Medicare. The alternative method substantially reduced the Medicare Advantage scores, bringing them approximately level with fee-for-service scores. The paper put the payment consequence plainly: upcoding may have exaggerated how much the two populations’ risks differed and so raised payments to the plans.

What Is a Medicare Advantage Whistleblower Lawsuit?

Under the False Claims Act, a Medicare Advantage whistleblower lawsuit is a qui tam case brought by a private person on the government’s behalf. The law’s whistleblower provisions allow the government to join and take responsibility for pursuing the case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

The government can take up part of a whistleblower’s case. In the Sutter Health resolution announced in 2021, it pursued claims involving Palo Alto Medical Foundation while the relator continued claims involving other Sutter businesses.

When You Know Why the Payment Stayed Wrong

If your work exposed unsupported diagnoses, blocked refunds or certifications that contradicted internal findings, speak with our whistleblower experts about what the company knew. We connect the clinical record, the payment trail and the decisions inside the business to build your strongest Medicare Advantage whistleblower case. We bring in Medicare Advantage whistleblower lawyers who understand risk-adjustment data and repayment disputes, and stay beside you through the case.